Influence of the epiretinal membrane on ranibizumab therapy outcomes in patients with diabetic macular edema
Arquivos Brasileiros de Oftalmologia, cilt.79, sa.6, ss.373-375, 2016 (SCI-Expanded, Scopus)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 79 Sayı: 6
- Basım Tarihi: 2016
- Doi Numarası: 10.5935/0004-2749.20160106
- Dergi Adı: Arquivos Brasileiros de Oftalmologia
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
- Sayfa Sayıları: ss.373-375
- Anahtar Kelimeler: Diabetic complications, Drug therapy, Epiretinal membrane, Macular edema, Ranibizumab/therapeutic use, Retinopathy
- Sağlık Bilimleri Üniversitesi Adresli: Evet
Özet
Purpose: To investigate the influence of the epiretinal membrane (ERM) on intravitreal ranibizumab (IVR) therapy for diabetic macular edema (DME). Methods: This retrospective study included 56 eyes of 48 patients with DME divided into two groups: the DME with ERM (study) and only DME (control) groups. Changes in the central macular thickness (CMT) and best-corrected visual acuity (BCVA) were evaluated. Results: In the study group, although the CMT was significantly reduced following the first injection (p < 0.001), BCVA did not improve significantly (p=0.296). However, after the first injection, the control group exhibited both a significant decrease in CMT (p < 0.001) and improvement in BCVA (p < 0.001). However, the improvement in BCVA in the control group was not significantly different from the outcome of the study group. Conclusions: We observed a negative short-term influence of the ERM on IVR treatment for DME.